Old Web
English
Sign In
Acemap
>
Paper
>
26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial
26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial
2021
Kristina Callis Duffin
Linda Stein Gold
Craig L. Leonardi
David M. Pariser
Lawrence Green
Howard Sofen
Bruce E. Strober
M. Chen
Yao Wang
Kim A. Papp
Keywords:
plaque psoriasis
Apremilast
in patient
Dermatology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]